wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38745816-10DF85E2-38DD-4188-931E-21DE4BC56685
Q38745816-10DF85E2-38DD-4188-931E-21DE4BC56685
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38745816-10DF85E2-38DD-4188-931E-21DE4BC56685
Addition of the p110α inhibitor BYL719 overcomes targeted therapy resistance in cells from Her2-positive-PTEN-loss breast cancer.
P2860
Q38745816-10DF85E2-38DD-4188-931E-21DE4BC56685
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38745816-10DF85E2-38DD-4188-931E-21DE4BC56685
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ef4ca3adbc90104c98938c89c4e81c39a4c92a3d
P2860
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.